Acquired and Heritable Thrombophilia in Indian Patients With Pediatric Deep Venous Thrombosis (DVT)

Clin Appl Thromb Hemost. 2014 Sep;20(6):573-6. doi: 10.1177/1076029613476339. Epub 2013 Feb 12.

Abstract

Deep venous thrombosis (DVT) in children is more often associated with underlying pathological conditions than with hereditary thrombophilia. The present study is a retrospective analysis of thrombophilia in 285 pediatric patients with venous thrombosis at different sites. Four common thrombophilia markers, that is protein C, protein S, antithrombin III, and factor V Leiden (FVL) mutation, were analyzed. Thrombosis in hepatic and portal veins was more common in pediatric patients (73%) when compared to other sites (27%). Overall, hereditary thrombophilia accounted for 15.5% of the patients with venous thrombosis. The FVL mutation, which was the major causative factor in Budd-Chiari syndrome and portal vein thrombosis cases in the adult group, was not a major contributing factor in pediatric group, that is, 1.8% of the patients. In conclusion, the risk factors for venous thrombosis vary in different age groups.

Keywords: Budd–Chiari syndrome; deep venous thrombosis; infection; portal venous thrombosis; thrombophilia.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Antithrombin III / metabolism*
  • Biomarkers / blood
  • Budd-Chiari Syndrome* / blood
  • Budd-Chiari Syndrome* / etiology
  • Budd-Chiari Syndrome* / genetics
  • Child
  • Child, Preschool
  • Factor V* / genetics
  • Factor V* / metabolism
  • Female
  • Humans
  • India
  • Infant
  • Male
  • Mutation*
  • Protein C / metabolism*
  • Protein S / metabolism*
  • Thrombophilia* / blood
  • Thrombophilia* / complications
  • Thrombophilia* / genetics

Substances

  • Biomarkers
  • Protein C
  • Protein S
  • factor V Leiden
  • Antithrombin III
  • Factor V

Supplementary concepts

  • Thrombophilia, hereditary